Pharmacokinetics of fosfomycin in chickens after a single intravenous dose and tissue levels following chronic oral administration

Veterinary Research

Volumn 28, Issue 6, 1997, Pages 581-588

  Aramayona, J J ^a   Bregante, M A ^a   Solans, C ^a   Rueda, S ^a   Fraile, L J ^a   Garcia, M A ^a  

^a UNIVERSIDAD DE ZARAGOZA   (Spain)

Author keywords

Chicken; Fosfomycin; Intravenous administration; Oral administration; Pharmacokinetics; Tissue levels

Indexed keywords

FOSFOMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHICKEN; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG TISSUE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS;

EID: 0030671472     PISSN: 09284249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bouchet JL, Albin H, Quentin C, De Barbeyrac B, Vinçon G, Martin-Dupont P, Potaux L, Aparicion M (1988) Pharmacokinetics of intravenous and intraperitoneal fosfomycin in continuous ambulatory peritoneal dialysis. Clin Nephrol 29, 35-40
2. Dalet F, Bade G, Koda M (1977) Pharmacokinetics of fosfomycin during hemodialysis. Chemotherapy 23 (Suppl 1), 210-213
3. Escudero ME, Eiguer T, Caffer MI, Fronchkowsky B, Fernandez M, Stefanini AM (1991) Yersinia enterocolitica strains from cows isolated at San Luis, Argentina. Revista Latinoamericana de Microbiofogia 33, 121-125
4. Fernandez C, Mariño EL, Dominguez A (1986) Linearity of the pharmacokinetics of phosphomycin in serum and interstitial tissue fluid in rabbits. Arzneim Forsch 36, 1518-1520
5. Frost BM, Valiant ME, Benson L, Dulaney EL (1974) Activity of fosfomycin against Pasteurella. Avian Dis 18, 578-589
6. Gobernado M, Canton E, Santos M, Vila B (1987) Antimicrobial profile of fosfomycin after 12 years use in a general hospital. In: Fosfomycin. Proceedings of the International Symposium (I Zabala, D Stanboulian, eds). Instituto de Farmacologia Española (CEPA). Madrid, Spain, 6-12
7. Goto S (1977) Fosfomycin, antimicrobial activity in vitro and in vivo. Chemotherapy 23 (Suppl 1), 63-74
8. Goto M, Sugiyama M, Nakajima S, Yamashina H (1981) Fosfomycin kinetics after intravenous and oral administration to human volunteers. Antimicrob Agents Chemother 20, 393-397
9. Gutierrez CB, Rodriguez EF (1993) In vitro susceptibility of Pasteurella multocida spp. multocida strains isolated from swine to 42 antimicrobial agents. Zentralbl Bakteriol 279, 387-393
10. Ishizawa T, Hayashi M, Awazu S (1991) Paracellular and transcellular permeabilities of fosfomycin across small intestinal membrane of rat and rabbit by voltage-clamp method. J Pharmacobio-dynamics 14, 583-590
11. Kawabata N, Shiraha Y, Doi S, Unemura K, Yaginuma K (1978) A study on serum levels and urinary excretion of fosfomycin-Na in man with special reference to pharmacokinetic analysis. Jpn J Antibiotics 31, 549-560
12. Kobayashi T, Baba S (1992) Experimental study on intramaxillary injection of fosfomycin: Effects of fosfomycin on experimental acute sinusitis in rabbits. Jpn J Antibiotics 45, 1319-1331
13. Neu HC, Kamirura T (1981) In vitro and in vivo antibacterial activity of F.R. - 3164, a phosphonic acid antimicrobial agent. Antimicrob Agents Chemother 19, 1013-1023
14. Piriz S, Cuenca R, Valle J, Vallido S (1992) Susceptibilities of anaerobic bacteria isolated from animals with ovine foot rot to 28 antimicrobial agents. Antimicrob Agents Chemother 36, 198-201
15. Yaginuma K, Murata S, Umemura K, Tomono N, Kikai S, Fujita M (1978) Pharmacokinetics of intravenous preparation of fosfomycin sodium salt in the rabbit and the dog. Jpn J Antibiotics 5, 465-473
16. Woodruff HB, Mata JM, Hernandez S, Mochales S, Rodriguez A, Stapley EO, Wallick H, Miller AK, Hendlin D (1977) Fosfomycin: Laboratory studies. Chemotherapy 23 (Suppl 1), 1-22